Experimental Chinese vaccine creates antibodies for more than six months
The Chinese CDC, without referring to which vaccine candidate was used, puts Chinese developers neck and neck with those in the West
Beijing — The amount of Covid-19 antibodies in trial subjects who received China’s experimental vaccines remained high six months after the first shots, a top Chinese scientist has said, projecting confidence that the country will be among the first to produce effective inoculation against the coronavirus.
The high levels detected in volunteers who took part in the earliest clinical trials suggest that the shots are effective and can provide immunity against the virus for an extended period of time, though final-stage testing results still need to be evaluated, Zeng Guang, chief scientist of the Chinese Centre for Disease Control and Prevention, said in a briefing in Beijing on Friday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.